Literature DB >> 7944725

Another approach for aortic valve replacement through left thoracotomy.

H Hirose1, S Umeda, Y Mori, S Murakawa, K Azuma, T Hashimoto.   

Abstract

We report a 54-year-old man with a history of esophagectomy and retrosternal esophagogastric anastomosis for esophageal cancer through right thoracotomy in whom cardiac failure developed due to aortic regurgitation. He underwent aortic valve replacement through a left thoracotomy with division of two great arteries and their strong traction toward the surgeon by stay sutures. He has been well for 3 years postoperatively in New York Heart Association class I.

Entities:  

Mesh:

Year:  1994        PMID: 7944725     DOI: 10.1016/0003-4975(94)90777-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Aortic valve replacement after retrosternal gastric tube reconstruction for esophageal cancer.

Authors:  H Matsuda; M Okada; C Yamashita; T Sugimoto; Y Watanabe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-05

2.  Aortic valve replacement through a minimally invasive approach.

Authors:  V De Amicis; R Ascione; G Iannelli; L Di Tommaso; M Monaco; N Spampinato
Journal:  Tex Heart Inst J       Date:  1997

3.  Alternative approach for aortic valve replacement: in mediastinal deviation after right lobectomy.

Authors:  Kyokun Uehara; Koji Ueyama; Hidehiro Ito; Kenichi Sasaki; Ryuji Nohara
Journal:  Tex Heart Inst J       Date:  2010

4.  Aortic valve replacement for a patient with porcelain aorta and retrosternal gastric tube reconstruction after esophageal resection.

Authors:  Hiroshi Takami; Yuichiro Doki; Kenji Yachiku; Daisuke Takeuchi; Jun Arisawa; Tohru Kobayashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-12

5.  Aortic valve replacement via right anterolateral thoracotomy in the case of a patient with extreme mediastinal right-shift following pneumonectomy.

Authors:  Mathias Wilhelmi; Thomas Rodt; Issam Ismail; Axel Haverich
Journal:  J Cardiothorac Surg       Date:  2013-01-25       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.